Naprosyn Suspension Re-listed by PBS

by / Wednesday, 18 January 2006 / Published in News

On April 1st 2006 patients will have access to the liquid formulation of Naprosyn (naproxen) through the Pharmaceutical Benefits Scheme.

This completes a two year joint project between LINK Pharmaceuticals and Roche Products to secure the long-term supply of this product in Australia for the treatment of chronic arthropathies and bone pain for patients unable to take solid forms of NSAIDS.

Moving ahead, Roche will continue to market solid Naprosyn formulations and LINK will distribute and co-promote the more specialist liquid formulation.

For further information please contact the Customer Service Department of LINK Pharmaceuticals.